What Happened
Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies | Eli Lilly and Company investor.lilly.comExclusive | Eli Lilly Strikes Deal for Cancer Biotech WSJEli Lilly agrees to acquire cancer drug maker Kelonia in deal worth up to $7 billion CNBCLilly to buy Kelonia Therapeutics for up to $7 billion to boost cancer pipeline ReutersLilly in advanced talks to acquire Kelonia Therapeutics for over $2 billion, WSJ says Yahoo
Why It Matters
This development may influence policy, markets, and public sentiment based on how events unfold.
Background Context
Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies | Eli Lilly and Company investor.lilly.comExclusive | Eli Lilly Strikes Deal for Cancer Biotech WSJEli Lilly agrees to acquire cancer drug maker Kelonia in deal worth up to $7 billion CNBCLilly to buy Kelonia Therapeutics for up to $7 billion to boost cancer pipeline ReutersLilly in advanced talks to acquire Kelonia Therapeutics for over $2 billion, WSJ says Yahoo
What To Watch Next
Track official statements, independent verification, and regional impact updates in the next 24 to 48 hours.
Editorial Next Step
Add your local context, fact checks, quotes, and analysis before or after publication.
Source: Business – Latest – Google News – Original Link
Source: Business – Latest – Google News
